T cell cross-priming by PD-L1(+) type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1x4-1BB bispecific antibody. (linkinghub.elsevier.com)

Authors: Luri-Rey C … Melero I Journal: Immunity Published: 2026-10-28 DOI: https://doi.org/10.1016/j.immuni.2026.10.003